Baxter Bros’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Baxter Bros's GILD Position: Q4 2018 in Review
Baxter Bros sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,410 shares — an estimated $263K sold.
Baxter Bros first reported a position in GILD in Q4 2013 and held it in 16 quarters. The position peaked at $1.19M in Q4 2015. 1,498 funds tracked by Wall St. Rank hold GILD as of Q4 2018.
- Baxter Bros reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
- Baxter Bros sold 3,410 Gilead Sciences shares in Q4 2018, an estimated $263K.
- Baxter Bros first reported a position in Gilead Sciences in Q4 2013 and held it in 16 quarters.
- Baxter Bros's Gilead Sciences position peaked at $1.19M in Q4 2015.
- 1,498 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.
Based on Baxter Bros's 13F filing for Q4 2018, filed 22 Jan 2019.